Back to the main directory
Press Release
- Man Group PLC : Form 8.3 - Barratt Developments plc by GlobeNewsWire
- Edison issues update on abrdn Asian Income Fund (AAIF): All looking good in terms of income and growth by EQS Group AG
- Parsons Selected to Design the Future Newark Bay Bridge, Advancing Transportation throughout New Jersey by GlobeNewsWire
- Chart Industries to Supply Key Liquefaction Equipment for the Cedar LNG Project by GlobeNewsWire
- Mobilicom to Unveil Unprecedented Comprehensive Solution for Uncrewed Vehicle Systems at AUVSI XPONENTIAL 2024 by GlobeNewsWire
- Granite Real Estate Investment Trust and Granite REIT Inc. Announce Proposal to Unwind Stapled Unit Structure by BusinessWire
- AngloGold Ashanti: Notice of 2024 Annual General Meeting by BusinessWire
- Descartes’ Study Reveals 54% of Supply Chain and Logistics Operations are Prioritizing Automation to Mitigate Workforce Shortages by GlobeNewsWire
- Granite Announces Timing of Earnings Release and Investor Conference Call by BusinessWire
- Can-Fite: Scientific Article Published by KOL Presents Namodenoson as a Promising Drug Candidate to Treat Advanced Liver Cancer and MASH by BusinessWire
- US Foods to Host 2024 Investor Day by BusinessWire
- Inside information: Meriaura Energy signs a contract with Serres Vermeil SARL to deliver a solar thermal plant in Palau-del-Vidre, France by GlobeNewsWire
- Multitude SE: Distribution of Own Shares to Employees Based on Matching Share Plan Vesting by GlobeNewsWire
- TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures by GlobeNewsWire
- Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer by GlobeNewsWire
- Bio-Path Holdings Expands Global Patent Portfolio by GlobeNewsWire
- Marimaca Copper Project Development and Exploration Update by GlobeNewsWire
- Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer by GlobeNewsWire
- Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment with GTX-102 by GlobeNewsWire
- Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida by GlobeNewsWire
- Ocular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessich is Stepping Down as President and CEO by GlobeNewsWire
- EQS-News: Multitude SE: Distribution of Own Shares to Employees Based on Matching Share Plan Vesting by EQS Group AG
- Kraig Biocraft Laboratories Announces Successful Launch of Spring Production Trials in Southeast Asia for Spider Silk by GlobeNewsWire
- EQS-News: www.fondsboutiquen.de: Ökosystem „Finanzplatz Frankfurt“, Crypto Assets Conference CAC24 (15.4. & 16.4.2024), Frankfurt School Blockchain Center, Family Offices, Knowhow & MORE - LinkedIn-Kanäle by EQS Group AG
- Hillman Sets First Quarter 2024 Earnings Release and Results Presentation Date by GlobeNewsWire